Navigation Links
Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting
Date:10/16/2009

hes.

In a medical study of patients with JIA, infection, headache, abdominal pain, vomiting, and nausea occurred more frequently than in adults. The kinds of infections reported were generally mild and similar to those usually seen in children. Other serious adverse reactions were reported, including serious infection and depression/personality disorder.

If you have any questions about this information, be sure to discuss them with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Please see Prescribing Information and Medication Guide.

About Amgen and Pfizer

Amgen and Pfizer market ENBREL in North America. Pfizer markets ENBREL outside of North America. Immunex Corporation, a wholly owned subsidiary of Amgen, manufactures ENBREL.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and anim
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
2. Plastic Surgery 2009 News Briefs - Selected Research to be Presented on Tuesday, October 27
3. Plastic Surgery 2009 News Briefs - Selected Research to be Presented on Monday, October 26
4. Plastic Surgery 2009 News Briefs - Select Research to be Presented on Sunday, October 25
5. Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24
6. Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics (TCT) 2009
7. PolyOne Presented with Frost & Sullivan Medical Product Award
8. CRF announces featured clinical trials to be presented at TCT 2009 in San Francisco
9. Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting
10. Centers of Excellence Awards Presented to Over 100 Nursing Facilities as Nursing Facilities Reach the Tipping Point in Treating Pressure Ulcers
11. CRF announces late breaking trials to be presented at TCT 2009 in San Francisco

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... New York personal injury ...to have the number of a personal injury attorney a...ds in a local Long Island backyard. , ...9 -- New York personal injury attorney David Per...that everyone should have the number of a personal...
(Date:11/24/2009)... Mercy Health System will ...IK surgery hosted by Robert Epstein, MD, board cer...y. Register today at www.MercyWebinars.com , ... Mercy Health System will present a live webinar o...essed through an office or home computer and is fr...
(Date:11/24/2009)..., SOMERSET,N.J.,Nov.24/PRNewswire-FirstCall/-...ealthcareandadministrativestaffingservices,todayan...commonstockfromTheNasdaqGlobalMarkettoTheNasdaqCap...beeffectiveattheopeningofbusinessonWednesday,Novem...otradeunderthesymbol"TSTF."TheNasdaqCapitalMarketi...
(Date:11/24/2009)..., MORRISVILLE,N.C.,Nov.24/PRNewswire/--TheAme...nitialresultsofasurveyabouttheimpactofthe2010CMSPh...e1,200cardiologistsandcardiovascularultrasoundtech...dforcethemtostopacceptingMedicarepatients,reducest...ducingpatientaccesstoechocardiography(heartultraso...
(Date:11/24/2009)...xposure in infancy may lead to persistent wheezing...thDay News) -- Infants exposed to outdoor traffic ...sk for asthma, researchers say. , Endotoxin -- ...une response in humans -- is found in dust. , U...chers found persistent wheezing (an early warning ...
Breaking Medicine News(10 mins):Health News:A New York Neighborhood Gets Hit Hard When A Piece Breaks Off A Plane 2Health News:A New York Neighborhood Gets Hit Hard When A Piece Breaks Off A Plane 3Health News:Free LASIK Surgery Webinar 2Health News:Free LASIK Surgery Webinar 3Health News:Free LASIK Surgery Webinar 4Health News:TeamStaff Announces Transfer to Nasdaq Capital Market 2Health News:TeamStaff Announces Transfer to Nasdaq Capital Market 3Health News:Lives Compromised and Patient Access Limited with New Cuts to Medicare 2Health News:Traffic, Dust Linked to Asthma in Kids 2
...unty Memorial Hospital (BCMH), a 60-bed acute hos...nix financial and patient management system. The M...ent access, revenue cycle management and financial...nded in 1992, CHS, MedGenix financial and clinical...
...ight today officially introduced QuietDose (TM)...records a worker,s actual in-ear exposure to noise... major advance towards stopping the progression of...ood the data they,re based upon. Existing noise m...
...dy led by researchers at Columbia University Medic... are several factors that contribute to children m...e reported in a platform presentation at 8:30 a.m.... young children are under-immunized, and previous ...
...Hispanic Family Physicians in California , , LOS...ente announced today a $2 million grant to the Dav...ifornia, Los Angeles , to expand its International... and need to pass United States Medical Licensing ...
...reatment of patients with non-small cell lung canc...oday announces U.S. commercial availability of Ver...patients with advanced stage non-small cell lung c...rosine kinase inhibitors (EGFR-TKIs), such as erlo...
...h control methods needs more study , , TUE...erone may be an effective form of male contracepti...njected 1,045 healthy, fertile Chinese men aged 20...had a normal medical history and had fathered at l...
Other Medicine News:Health News:MedGenix Financial Information System Selected by Bates County Memorial Hospital 2Health News:Howard Leight Introduces QuietDose(TM): In-Ear Dosimetry Measures Noise Exposure in Real-Time to Help Prevent Workplace Hearing Loss 2Health News:Howard Leight Introduces QuietDose(TM): In-Ear Dosimetry Measures Noise Exposure in Real-Time to Help Prevent Workplace Hearing Loss 3Health News:Howard Leight Introduces QuietDose(TM): In-Ear Dosimetry Measures Noise Exposure in Real-Time to Help Prevent Workplace Hearing Loss 4Health News:Why parents miss their children's immunization visits 2Health News:Why parents miss their children's immunization visits 3Health News:Kaiser Permanente Grant to Expand UCLA International Medical Center Graduate Program 2Health News:Kaiser Permanente Grant to Expand UCLA International Medical Center Graduate Program 3Health News:Kaiser Permanente Grant to Expand UCLA International Medical Center Graduate Program 4Health News:Biodesix Advances the Field of Personalized Medicine With the Launch of VeriStrat(R) 2Health News:Biodesix Advances the Field of Personalized Medicine With the Launch of VeriStrat(R) 3Health News:Testosterone Injections Offer Hope for Male Contraceptive 2
(Date:11/24/2009)...re/--SatelliteHealthcare,oneofthenation,sfirstandl...onsorofnephrologyresearch,todayannounceditsfullsup...isefforttosupporttheSanJosehomelessthisThanksgivin...erasachefforthepast20years.ButNasrallah,slifewastu...EndStageRenalDisease(ESRD).Thediagnosisirrevocably...
(Date:11/24/2009)...irstCall/--IsisPharmaceuticals,Inc.(Nasdaq: ISIS )...atmanagementwillpresentacompanyoverviewatPiperJaff...ber1,2009,at10:30a.m.ETatTheNewYorkPalaceHotel. ,...bleonthe"Investors&Media"sectionoftheCompany,s...onwillbeavailableontheIsisWebsitewithin48hoursandw...
(Date:11/24/2009)...l/--OptimerPharmaceuticals,Inc.(Nasdaq: OPTR )issc...areConferenceatTheNewYorkPalaceinNewYorkCityonDece...://www.newscom.com/cgi-bin/prnh/20090413/LA97352LO...beaccessibleontheInvestorspageoftheCompany,swebsit...tionwillbeavailableatthesamelocationfor30daysfollo...
Breaking Medicine Technology:Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2Critical Zone Observatory seeks to answer climate change questions 10146 1Critical Zone Observatory seeks to answer climate change questions 10146 2Critical Zone Observatory seeks to answer climate change questions 10146 3Critical Zone Observatory seeks to answer climate change questions 10146 4A pet in your life keeps the doctor away 10143 1A pet in your life keeps the doctor away 10143 2A pet in your life keeps the doctor away 10143 3Clot Busting Therapy Under Review 58424 1Clot Busting Therapy Under Review 58424 2Clot Busting Therapy Under Review 58424 3
...stration Signifies Completion of First Disease Dat...nostic System, SEATTLE, April 29 VentriPoint Dia...nstruction (KBR) enables accurate three,dimensiona...unction in,patients with tetralogy of fallot (TOF)...han currently applied methods., TOF is a disease ...
...sequent Phase 1b study planned for mid 2008 with P... 2008 or in early 2009 -, SAN CARLOS, Calif., Apr...ed positive results from the Phase 1,proof-of-conc...thrombin-inhibitor achieved rapid onset and offset... a favorable safety profile., "There is a signifi...
Other Medicine Technology:Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular Volume and Function in Tetralogy of Fallot Patients, According to VentriPoint Diagnostics 2Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 2Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 3Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 4
Seditainer Blood Collection Tube For Erythrocyte Sedimentation Rate Determination
...22® Test Kit is a quantitative microplate enzy...tients who are at risk for rapid recurrence or occ...ded urine sample and is twice as sensitive as urin...rove patient outcome by identifying those patients...
Hemoccult SENSA Fecal Occult Blood Test
Luna Fertility Indicator
Medicine Products: